Faeth Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	152.33	8.67	9.99	13.01	17.8	7.16
Short-Term Investments	50.47	12.52	31.34	52.75	89.32	140.46
Cash & Short-Term Investments	202.79	21.18	41.34	65.76	107.12	147.62
Cash Growth	490.70%	-48.75%	-37.14%	-38.61%	-27.44%	789.50%
Other Current Assets	1.44	0.32	0.59	1.49	1.47	0.92
Total Current Assets	204.23	21.51	41.93	67.25	108.59	148.54
Net Property, Plant & Equipment	0.98	1.38	3.38	7.04	9.72	4.64
Other Long-Term Assets	0.17	0.02	0.05	0.09	0.06	0.04
Total Assets	205.38	22.9	45.36	74.37	118.38	153.23
Accrued Expenses	13.15	2.8	3.13	3.2	6.94	4.21
Current Portion of Leases	1.04	1.45	2.32	2.44	2.13	0.68
Total Current Liabilities	14.19	4.25	5.45	5.64	9.07	4.89
Long-Term Leases	-	0.06	1.53	3.77	5.9	1.67
Other Long-Term Liabilities	0	-	-	0.07	-	0.15
Total Long-Term Liabilities	0	0.06	1.53	3.84	5.9	1.82
Total Liabilities	14.19	4.31	6.98	9.48	14.97	6.71
Preferred Stock	328.48	-	-	-	-	-
Common Stock	-	-	-	0	0	0
Additional Paid-in Capital	316.11	301.73	300.45	297	302.2	296.05
Accumulated Other Comprehensive Income	-0.02	0	-0.01	-0.21	-1	-0.33
Retained Earnings	-453.37	-283.14	-262.05	-231.9	-197.79	-149.21
Shareholders' Equity	-137.29	18.59	38.39	64.9	103.41	146.51
Total Liabilities & Equity	205.38	22.9	45.36	74.37	118.38	153.23
Total Debt	1.04	1.51	3.85	6.21	8.03	2.35
Net Cash (Debt)	201.75	19.68	37.49	59.55	99.08	145.27
Net Cash Growth	925.43%	-47.52%	-37.04%	-39.90%	-31.79%	813.00%
Net Cash Per Share	158.91	15.61	29.85	42.61	64.54	104.85
Book Value	-137.29	18.59	38.39	64.9	103.41	146.51
Book Value Per Share	-108.13	14.75	30.57	46.43	67.36	105.75
Tangible Book Value	-137.29	18.59	38.39	64.9	103.41	146.51
Tangible Book Value Per Share	-108.13	14.75	30.57	46.43	67.36	105.75

SEC Filings: 10-K · 10-Q